Abivax raises $920 million after capital increase
Abivax completes a $920 million fundraising.
Published 2sem1 sourceNotableupdated 2sem
Lire en français
≈ 14s
The fact
The operation, conducted with institutional investors, aims to fund its clinical trials.
This cash injection strengthens its treasury for the next two years.
Click the link to read an article on the topic: